PATENT CLAIM ANALYSIS

Application Number: 16239461
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "653000"]

Abstract:
The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-norepinephrine and exhibit less than 5% degradation of total norepinephrine.

Claim (Index 7):
The sterile, ready-to-administer, packaged norepinephrine composition of  claim 1 , wherein the secondary container is impervious to light of a wavelength that promotes photo-initiated degradation of the norepinephrine or salt thereof in the sterile, ready-to-administer norepinephrine composition.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.2973
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16239465', '16163476', '15883798', '16163480', '15949736']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8442389409380096
- 35 USC 102 Novelty (BERT): 0.5617207730395778
- Combined Prediction Score: 0.8159871241481664
- Mean Citation Score: 450.82184799999993
- Max Citation Score: 471.39062
- Similarity Product: 327.50175718968154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test